|
|
Sub Investigator Silver AMI: Observational study designed to collect data about the post –AMI recovery period that will be used to generate risk models for older patients with AMI. National Heart,
Lung, and Blood Institute (NHLBI) and Yale University. New Haven, CT.
Sub Investigator (August 2015 – Present) ARTEMIS: A prospective, cluster-randomized clinical trial that will evaluate whether patient copayment reduction significantly influences antiplatelet therapy selection and long-term adherence, as well as patient outcomes and overall cost of care after acute myocardial infarction. AstraZeneca and Duke Clinical Research Institute (CRO). Raleigh/Durham, NC.
Sub Investigator (January 2012 – Present) BIOFLEX I: A Phase II clinical evaluation of safety and efficacy study of the Biotronik Astron and Astron-Pulsar stents used in the treatment of femoro-popliteal lesions located in the native SFA or PPA in patients presenting with life limiting PVD. Biotronik, Inc. Lake Oswego, OR.
Sub Investigator (May 2014 – Present) TIGRIS: Long term risk, clinical management, and healthcare resource utilization of stable coronary artery disease in post myocardial infarction patients, AstraZeneca. Sodertalje, Sweden and Worldwide Clinical Trials (CRO). London, England.
Sub Investigator (August 2012 – February 2015) ABSORB III: Clinical evaluation of the ABSORB Everolimus eluting bioresorbable vascular scaffold (BVS) in the treatment of subjects with de novo native coronary artery lesions. Abbott Vascular. Santa Clara, CA.
|
